Medtronic announced its intention to acquire SPR Therapeutics, while Goldman Sachs reinstated its coverage of Medtronic with a Neutral rating.
1 report, 1 independent
Updated Jun 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Medtronic announced its intention to acquire SPR Therapeutics, while Goldman Sachs reinstated its coverage of Medtronic with a Neutral rating.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Medtronic plc
medical device company
-
Goldman Sachs
American investment bank